Life Beyond Provenge: Dendreon Plans To Move First Small Molecule Into The Clinic
This article was originally published in The Pink Sheet Daily
Executive Summary
While Dendreon awaits data to complete the prostate cancer vaccine’s BLA, other candidates progress.